Top compounds associated with response to EML6


Feature Type Standardized
Nominal ANOVA
mRNA 681640 GDSC1000 pan-cancer AAC 0.094 0.02
mRNA selumetinib:GDC-0941 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA RITA CTRPv2 pan-cancer AAC -0.084 0.02
mRNA AZD6482 CTRPv2 pan-cancer AAC 0.085 0.02
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.083 0.02
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA Talazoparib GDSC1000 pan-cancer AAC -0.082 0.02
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.083 0.02
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.077 0.02
mRNA Axitinib CTRPv2 pan-cancer AAC -0.077 0.02
Download CSV